Susquehanna International Group
AKYA

Susquehanna International Group’s Akoya BioSciences AKYA Stock Holding History

Susquehanna International Group’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-176,961
Closed -$230K – 12270
2025
Q2 		$230K Buy
176,961
+143,431
+428% +$173K ﹤0.01% 10921
2025
Q1 		$46.6K Sell
33,530
-8,022
-19% -$17.6K ﹤0.01% 11886
2024
Q4 		$95.2K Buy
41,552
+28,049
+208% +$74.3K ﹤0.01% 11379
2024
Q3 		$36.7K Buy
+13,503
New +$33K ﹤0.01% 11488
2023
Q3 		– Sell
-23,378
Closed -$134K – 11939
2023
Q2 		$173K Sell
23,378
-29,000
-55% -$194K ﹤0.01% 10424
2023
Q1 		$428K Sell
52,378
-39,128
-43% -$409K ﹤0.01% 8936
2022
Q4 		$876K Buy
+91,506
New +$1.13M ﹤0.01% 6475

Susquehanna International Group's AKYA Position: Q3 2025 in Review

Susquehanna International Group sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 176,961 shares — an estimated $230K sold.

Susquehanna International Group first reported a position in AKYA in Q4 2022 and held it in 7 quarters. The position peaked at $876K in Q4 2022. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.

  • Susquehanna International Group reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 176,961 Akoya BioSciences shares in Q3 2025, an estimated $230K.
  • Susquehanna International Group first reported a position in Akoya BioSciences in Q4 2022 and held it in 7 quarters.
  • Susquehanna International Group's Akoya BioSciences position peaked at $876K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.